Market Overview:
The global spinal cord stimulator market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of chronic pain, technological advancements in spinal cord stimulator devices, and rising demand for minimally invasive surgeries. Based on type, the global spinal cord stimulator market is segmented into by inserting type and by power type. By inserting type, the market is further segmented into percutaneous implantation and open surgery implantation. By power type, the market is further segmented into non-invasive and invasive devices. Non-invasive devices are expected to dominate the global spinal cord stimulator market during the forecast period owing to their ease of use and growing demand for minimally invasive surgeries. Based on application, the global spinal cord stimulator market is divided into failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), ischemic limb pain (ILP), and others (neuropathic pain, cancer pain). FBSS accounts for a major share of the global spinal cord stimulator application landscape owing to its high prevalence rate across all regions studied in this research study. CRPS also accounts for a significant share of this landscape due to its increasing incidence rates globally coupled with lack of effective treatment options available till date.
Product Definition:
A spinal cord stimulator is a device that sends electrical current to the spinal cord to block pain signals from traveling to the brain. The stimulator is implanted under the skin on the lower back and sends electrical impulses through thin wires called leads to electrodes placed on or near the spinal cord.
By Inserting type:
By Inserting type is a new term in the spinal cord stimulator market. It means that the lead wire of a spinal cord stimulator is passed through the hole in another body part to record electrical activity from muscles, nerves or skin of patient. By installing this device, it will help to get accurate results and avoid many errors which may cause severe damage to patient's health.
By Power type:
By power type, we mean the different ways in which spinal cord stimulators can produce electrical stimulation to the spinal cord. There are two main types of technologies used for this-bio-magnetic and electroceuticals.
Bio magnetic technology is a noninvasive technique that uses electromagnetic fields generated by an implantable pulse generator (IPG) to modulate or stimulate nerve traffic in the brain and body.
Application Insights:
The others segment dominated the global market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to an increase in patient population suffering from chronic pain conditions, such as neurogenic pain, lower back pain, neck pain and face Pain. According to a study published by NCBI in 2018, it was estimated that around 300 million people across the globe suffer from chronic pains. Furthermore, another study states that around 50 million people above 40 years of age are affected by acute low back pains every year in Europe alone and this number is increasing at a rapid pace. These factors are anticipated to boost spinal cord stimulators demand over the forecast period.
The failed back surgery syndrome segment accounted for a substantial revenue share of 23% globally owing to an increase in patients undergoing surgical procedures for treatment purposes or maintenance of spine health due largelyto rising prevalence rates of complex regional Pain Syndrome (CRPS).
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing prevalence of SCI and rising awareness about spinal cord stimulation therapy. Moreover, presence of key players such as Medtronic; Stryker; Boston Scientific Corporation; and Cyberonics in the region is also expected to boost growth over the forecast period. Increasing cases of chronic pain due to trauma injuries are driving regional growth. According to a study published by American Chiropractic Association, approximately 50% of adults suffer from lower back pain at least once per month and 30% experience it every week or more often.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to growing target population base suffering from neuropathic pain after spinal surgeries coupled with improving healthcare infrastructure in this region which will lead towards an increase in R&D activities for developing innovative products for treating neuropathic pain after surgery or during pregnancy etc.
Growth Factors:
- Increasing incidence of chronic pain: The global spinal cord stimulator market is expected to grow at a CAGR of 9.5% during the forecast period owing to the increasing incidence of chronic pain. According to the American Academy of Pain Medicine, around 100 million people in the U.S. suffer from chronic pain, which is a major growth driver for the market
- Rising geriatric population: The global spinal cord stimulator market is also expected to benefit from the rising geriatric population across the world. As per United Nations estimates, by 2050, around 1 in 5 people will be aged 60 years or above, which will drive demand for better treatment options for elderly patients suffering from various types of pain
- Technological advancements: Spinal cord stimulators are becoming more sophisticated with each passing day with technological advancements such as wireless technology and MRI-compatible devices opening up new opportunities for growth in this market space
Scope Of The Report
Report Attributes
Report Details
Report Title
Spinal Cord Stimulator Market Research Report
By Type
By Inserting type, By Power type
By Application
Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Ischemic Limb Pain, Others
By Companies
Boston Scientific Corp., Medtronic, St Jude, Nevro Corp, Nuvectra Corporation, Stimwave, Saluda Medical PTY Limited, Cyberonics, NeuroPace, Synapse Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Spinal Cord Stimulator Market Report Segments:
The global Spinal Cord Stimulator market is segmented on the basis of:
Types
By Inserting type, By Power type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Ischemic Limb Pain, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corp.
- Medtronic
- St Jude
- Nevro Corp
- Nuvectra Corporation
- Stimwave
- Saluda Medical PTY Limited
- Cyberonics
- NeuroPace
- Synapse Biomedical
Highlights of The Spinal Cord Stimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- By Inserting type
- By Power type
- By Application:
- Failed Back Surgery Syndrome
- Complex Regional Pain Syndrome
- Ischemic Limb Pain
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spinal Cord Stimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A spinal cord stimulator is a medical device that uses electrical stimulation to treat conditions such as chronic pain, spasticity, and paralysis.
Some of the major companies in the spinal cord stimulator market are Boston Scientific Corp., Medtronic, St Jude, Nevro Corp, Nuvectra Corporation, Stimwave, Saluda Medical PTY Limited, Cyberonics, NeuroPace, Synapse Biomedical.
The spinal cord stimulator market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Spinal Cord Stimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Spinal Cord Stimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Spinal Cord Stimulator Market - Supply Chain
4.5. Global Spinal Cord Stimulator Market Forecast
4.5.1. Spinal Cord Stimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Spinal Cord Stimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Spinal Cord Stimulator Market Absolute $ Opportunity
5. Global Spinal Cord Stimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Spinal Cord Stimulator Market Size and Volume Forecast by Type
5.3.1. By Inserting type
5.3.2. By Power type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Spinal Cord Stimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Spinal Cord Stimulator Market Size and Volume Forecast by Application
6.3.1. Failed Back Surgery Syndrome
6.3.2. Complex Regional Pain Syndrome
6.3.3. Ischemic Limb Pain
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Spinal Cord Stimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Spinal Cord Stimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Spinal Cord Stimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Spinal Cord Stimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Spinal Cord Stimulator Demand Share Forecast, 2019-2026
9. North America Spinal Cord Stimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Spinal Cord Stimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Spinal Cord Stimulator Market Size and Volume Forecast by Application
9.4.1. Failed Back Surgery Syndrome
9.4.2. Complex Regional Pain Syndrome
9.4.3. Ischemic Limb Pain
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Spinal Cord Stimulator Market Size and Volume Forecast by Type
9.7.1. By Inserting type
9.7.2. By Power type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Spinal Cord Stimulator Demand Share Forecast, 2019-2026
10. Latin America Spinal Cord Stimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Spinal Cord Stimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Spinal Cord Stimulator Market Size and Volume Forecast by Application
10.4.1. Failed Back Surgery Syndrome
10.4.2. Complex Regional Pain Syndrome
10.4.3. Ischemic Limb Pain
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Spinal Cord Stimulator Market Size and Volume Forecast by Type
10.7.1. By Inserting type
10.7.2. By Power type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Spinal Cord Stimulator Demand Share Forecast, 2019-2026
11. Europe Spinal Cord Stimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Spinal Cord Stimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Spinal Cord Stimulator Market Size and Volume Forecast by Application
11.4.1. Failed Back Surgery Syndrome
11.4.2. Complex Regional Pain Syndrome
11.4.3. Ischemic Limb Pain
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Spinal Cord Stimulator Market Size and Volume Forecast by Type
11.7.1. By Inserting type
11.7.2. By Power type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Spinal Cord Stimulator Demand Share, 2019-2026
12. Asia Pacific Spinal Cord Stimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Spinal Cord Stimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Spinal Cord Stimulator Market Size and Volume Forecast by Application
12.4.1. Failed Back Surgery Syndrome
12.4.2. Complex Regional Pain Syndrome
12.4.3. Ischemic Limb Pain
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Spinal Cord Stimulator Market Size and Volume Forecast by Type
12.7.1. By Inserting type
12.7.2. By Power type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Spinal Cord Stimulator Demand Share, 2019-2026
13. Middle East & Africa Spinal Cord Stimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Spinal Cord Stimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Spinal Cord Stimulator Market Size and Volume Forecast by Application
13.4.1. Failed Back Surgery Syndrome
13.4.2. Complex Regional Pain Syndrome
13.4.3. Ischemic Limb Pain
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Spinal Cord Stimulator Market Size and Volume Forecast by Type
13.7.1. By Inserting type
13.7.2. By Power type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Spinal Cord Stimulator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Spinal Cord Stimulator Market: Market Share Analysis
14.2. Spinal Cord Stimulator Distributors and Customers
14.3. Spinal Cord Stimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific Corp.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St Jude
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nevro Corp
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nuvectra Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Stimwave
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Saluda Medical PTY Limited
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cyberonics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. NeuroPace
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Synapse Biomedical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
